CIK 0001826667 · Non-accelerated filer<br>Smaller reporting company
TriSalus Life Sciences, Inc.
Sign in to watch- Ticker
- TLSI
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853009869
- Phone
- 415 336 8917
- Business address
- 6272 WEST 91ST AVENUE, WESTMINSTER, CO, 80031
- Former names
- MedTech Acquisition Corp, MedTech Acquisition Corporation
Securities
- TLSI Common Stock Nasdaq
- TLSIW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,113
- in 3 filings
Net −$4,113. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | Wahlstrom Mats Director | Grant or award · Director Stock Option (right to buy) | +15,000 | 200,945 | ||
| 2025-05-19 | Young James Emmett Chief Financial Officer | Grant or award | +13,175 | $5.18 | $68K | 49,663 |
| 2025-05-19 | Cox Bryan F. Chief of Research | Grant or award | +15,722 | $5.18 | $81K | 124,179 |
| 2025-05-19 | Cox Bryan F. Chief of Research | Sale | −4,764 | $5.18 | $25K | 119,415 |
| 2025-05-19 | Devlin Jodi Chief of Clinical Operations | Grant or award | +24,131 | $5.18 | $125K | 57,528 |
| 2025-05-19 | Devlin Jodi Chief of Clinical Operations | Sale | −4,764 | $5.18 | $25K | 52,764 |
| 2025-05-19 | Marshak Richard Chief Commercial Officer | Grant or award | +21,428 | $5.18 | $111K | 75,698 |
| 2025-05-19 | Marshak Richard Chief Commercial Officer | Sale | −6,597 | $5.18 | $34K | 69,101 |
| 2025-05-19 | Murphy Sean Director | Grant or award | +44,884 | $5.18 | $232K | 123,989 |
| 2025-05-19 | Stevens Jennifer Chief Regulatory Officer | Grant or award | +28,455 | $5.18 | $147K | 86,344 |
| 2025-05-19 | Stevens Jennifer Chief Regulatory Officer | Sale | −8,704 | $5.18 | $45K | 77,640 |
| 2025-02-18 | Murphy Sean Chief Manuf, Strategy&Bus Dev. | Grant or award | +15,817 | 79,105 | ||
| 2025-02-18 | Young James Emmett Chief Financial Officer | Grant or award | +14,762 | 36,488 | ||
| 2025-02-18 | Stevens Jennifer CHIEF REGULATORY OFFICER | Grant or award | +14,481 | 57,889 | ||
| 2025-02-18 | Cox Bryan F. CHIEF OF RESEARCH | Grant or award | +11,450 | 108,457 | ||
| 2025-02-18 | Marshak Richard Chief Commercial Officer | Grant or award | +7,644 | 54,270 | ||
| 2025-02-18 | Szela Mary T CEO AND PRESIDENT | Grant or award | +21,089 | 465,348 | ||
| 2025-02-18 | Devlin Jodi Chief of Clinical Operations | Grant or award | +5,272 | 33,397 | ||
| 2025-02-10 | MATLIN DAVID J Director | Other acquisition · Series A Preferred Stock | +89,501 | 189,501 | ||
| 2025-02-10 | Wahlstrom Mats Director | Other acquisition · Series A Convertible Preferred Stock | +44,750 | 94,750 |
Page 5 of 9 · 161 trades